BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 36923009)

  • 1. Progressive pulmonary fibrosis in patients with connective tissue disease-associated interstitial lung disease: An explorative study.
    Höppner J; Wollsching-Strobel M; Schumacher F; Windisch W; Berger M
    Arch Rheumatol; 2024 Mar; 39(1):46-51. PubMed ID: 38774704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting.
    Torrisi SE; Kahn N; Wälscher J; Polke M; Lee JS; Molyneaux PL; Sambataro FM; Heussel CP; Vancheri C; Kreuter M
    Front Pharmacol; 2021; 12():790204. PubMed ID: 34975486
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of CT Quantification-Based Assessment in Defining Progressive Pulmonary Fibrosis.
    Ahn Y; Kim HC; Lee JK; Noh HN; Choe J; Seo JB; Lee SM
    Acad Radiol; 2024 Jun; ():. PubMed ID: 38876844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of progression in non-IPF fibrotic interstitial lung disease.
    Wells AU
    Curr Opin Pulm Med; 2023 Sep; 29(5):459-464. PubMed ID: 37417940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Autophagy and Apoptosis in Affected Skin and Lungs in Patients with Systemic Sclerosis.
    Spasovski V; Andjelkovic M; Parezanovic M; Komazec J; Ugrin M; Klaassen K; Stojiljkovic M
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
    Xie M; Zhu C; Ye Y
    BMC Pulm Med; 2023 Jul; 23(1):255. PubMed ID: 37434169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KL-6 levels in the connective tissue disease population: typical values and potential confounders-a retrospective, real-world study.
    Zhou A; Tang H; Peng W; Wang Y; Tang X; Yang H; Lu R; Pan P
    Front Immunol; 2023; 14():1098602. PubMed ID: 37409133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: The CRAFT Model.
    Guo J; Mei C; Yu Q; Huang A
    Med Sci Monit; 2023 Jun; 29():e940251. PubMed ID: 37317506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review.
    Shah Gupta R; Koteci A; Morgan A; George PM; Quint JK
    BMJ Open Respir Res; 2023 Jun; 10(1):. PubMed ID: 37308252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective Tissue Disease Associated Interstitial Lung Disease.
    Matson SM; Demoruelle MK
    Immunol Allergy Clin North Am; 2023 May; 43(2):229-244. PubMed ID: 37055086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosis.
    Ceribelli A; Tonutti A; Isailovic N; De Santis M; Selmi C
    Front Med (Lausanne); 2023; 10():1068402. PubMed ID: 37007784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study.
    Raman L; Stewart I; Barratt SL; Chua F; Chaudhuri N; Crawshaw A; Gibbons M; Hogben C; Hoyles R; Kouranos V; Martinovic J; Mulholland S; Myall KJ; Naqvi M; Renzoni EA; Saunders P; Steward M; Suresh D; Thillai M; Wells AU; West A; Mitchell JA; George PM
    ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 36949962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease.
    Fu H; Zheng Z; Zhang Z; Yang Y; Cui J; Wang Z; Xue J; Chi S; Cao M; Chen J
    Clin Rheumatol; 2023 Jul; 42(7):1917-1929. PubMed ID: 36929316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effect of progressive pulmonary fibrosis on patients with connective tissue disease-associated interstitial lung disease: a single center retrospective cohort study.
    Lee JK; Ahn Y; Noh HN; Lee SM; Yoo B; Lee CK; Kim YG; Hong S; Ahn SM; Kim HC
    Clin Exp Med; 2023 Dec; 23(8):4797-4807. PubMed ID: 37831431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive fibrotic interstitial lung disease.
    Pereira CAC; Cordero S; Resende AC
    J Bras Pneumol; 2023; 49(5):e20230098. PubMed ID: 37610955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostication of progressive pulmonary fibrosis in connective tissue disease-associated interstitial lung diseases: A cohort study.
    Chiu YH; Koops MFM; Voortman M; van Es HW; Langezaal LCM; Welsing PMJ; Jamnitski A; Wind AE; van Laar JM; Grutters JC; Spierings J
    Front Med (Lausanne); 2023; 10():1106560. PubMed ID: 36923009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the diagnostic criteria for progressive pulmonary fibrosis in connective tissue disease related interstitial lung disease.
    Lee J; Kim K; Jo YS
    Respir Med; 2023 Jun; 212():107242. PubMed ID: 37031806
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.